Shenzhen Xenotransplantation Medical Engineering Research and Development Center,
Institute of Translational Medicine,
Shenzhen Second People's Hospital,
Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital
Lisha Mou has not added Biography.
If you are Lisha Mou and would like to personalize this page please email our Author Liaison for assistance.
A dominant-negative mutation of HSF2 associated with idiopathic azoospermia.
Human genetics Feb, 2013 | Pubmed ID: 23064888
The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs.
International journal of molecular sciences Mar, 2015 | Pubmed ID: 25807262
Potential alternative approaches to xenotransplantation.
International journal of surgery (London, England) Nov, 2015 | Pubmed ID: 26209781
A functional variant in the UBE2B gene promoter is associated with idiopathic azoospermia.
Reproductive biology and endocrinology : RB&E Jul, 2015 | Pubmed ID: 26223869
Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation.
International journal of molecular sciences Aug, 2016 | Pubmed ID: 27490531
Potential Antigens Involved in Delayed Xenograft Rejection in a Ggta1/Cmah Dko Pig-to-Monkey Model.
Scientific reports 08, 2017 | Pubmed ID: 28855711
In vitro chemokine (C-C motif) receptor 6-dependent non-inflammatory chemotaxis during spermatogenesis.
Biological research May, 2018 | Pubmed ID: 29788995
Transplant Tolerance: Current Insights and Strategies for Long-Term Survival of Xenografts.
Archivum immunologiae et therapiae experimentalis Jul, 2018 | Pubmed ID: 29992337
Single-Field Non-Mydriatic Fundus Photography for Diabetic Retinopathy Screening: A Systematic Review and Meta-Analysis.
Ophthalmic research , 2019 | Pubmed ID: 31067550
TNF-α promotes human antibody-mediated complement-dependent cytotoxicity of porcine endothelial cells through downregulating P38-mediated Occludin expression.
Cell communication and signaling : CCS Jul, 2019 | Pubmed ID: 31307477
Association between Aldose Reductase Gene C(-106)T Polymorphism and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Ophthalmic research , 2020 | Pubmed ID: 31962334
First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen University Health Science Center
Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine
First Affiliated Hospital of Shenzhen University, Health Science Center
Shenzhen University School of Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital
First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital
Ying Lu*,1,
Shangyou Zou*,1,
Suzanne Bertera*,2,
Rita Bottino2,
David K.C. Cooper3,
Zhengzhao Liu1,
Yi Huang1,
Chengjun Wang1,
Chungu Hong1,
Tian He1,
Hancheng Zhang1,
Qin Huo4,
Hongxing Fu5,
Zhiming Cai1,
Lisha Mou1
1Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen University Health Science Center,
2Institute for Cellular Therapeutics, Allegheny-Singer Research Institute,
3Xenotransplantation Program/Department of Surgery, The University of Alabama at Birmingham,
4College of Life Science and Oceanography, Shenzhen University,
5School of Pharmcy, Wenzhou Medical College
Yanli Zhao1,2,3,
Chengjiang Zhao4,
David K.C. Cooper5,
Ying Lu2,
Kewang Luo6,
Huiyun Wang3,
Pengfei Chen3,
Changchun Zeng3,
Shaodong Luan1,
Lisha Mou2,
Hanchao Gao1,2,3
1Department of Nephrology, Shenzhen Longhua District Central Hospital, Affiliated Central Hospital of Shenzhen Longhua District, Guangdong Medical University,
2Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine,
3Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Affiliated Central Hospital of Shenzhen Longhua District, Guangdong Medical University,
4Department of Endocrinology, Shenzhen Longhua District Central Hospital, Affiliated Central Hospital of Shenzhen Longhua District, Guangdong Medical University,
5Xenotransplantation Program, Department of Surgery, University of Alabama at Birmingham,
6, People's Hospital of Longhua
Yuanzheng Peng*,1,
Zhicheng Zou*,1,
Jiao Chen1,
Hancheng Zhang1,
Ying Lu1,
Rito Bittino2,
Hongxing Fu3,
David K. C. Cooper4,
Shan Lin1,
Mengtao Cao1,
Yifan Dai5,
Zhiming Cai1,
Lisha Mou1
1Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Health Science Center,
2Institute for Cellular Therapeutics, Allegheny-Singer Research Institute,
3School of Pharmaceutical Sciences, Wenzhou Medical University,
4Xenotransplantation Program/Department of Surgery, University of Alabama at Birmingham,
5Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University
Yangyang Deng*,1,2,
Ming Zhou*,1,3,
Ying Lu1,
Jiao Chen1,
Zuhui Pu4,
Dongjing Yu1,5,
Yifan Dai6,
Yongqiang Zhan7,
Lisha Mou1
1Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen University Health Science Center, Shenzhen University School of Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
2, Xianning Hospital of Traditional Chinese Medicine,
3, Liver-biotechnology (Shenzhen) Co., Ltd.,
4Department of Radiology, Shenzhen University Health Science Center, Shenzhen University School of Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
5Department of Life Sciences, University of Toronto,
6Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University,
7Department of Hepatopancreatobiliary Surgery, Shenzhen University Health Science Center, Shenzhen University School of Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital
Ying Lu*,1,2,
Zuhui Pu*,3,
Jiao Chen2,
Jing Deng2,
Ying Deng2,4,
Shufang Zhu2,
Chunliang Xu5,
Fuwen Yao1,2,
Zijing Wu1,2,
Yong Ni1,
Yongqiang Zhan1,
Jun Cheng1,
Naiyang Zhan1,
Wenlong Huang6,
Zhiming Cai2,
Rita Bottino7,
Lisha Mou2
1Department of Hepatopancreatobiliary Surgery, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
2Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Shenzhen Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
3Imaging Department, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
4Faculty of Science, University of Waterloo,
5School of Life Science, The Chinese University of Hong Kong,
6General Surgery, The First Affiliated Hospital of Shantou University Medical College,
7Director Islet Programs, Imagine Pharma